ALPA LABORATORIES LTD. - 532878 - Outcome Of Board Meeting- Financial Results
Alpa Laboratories Limited has submitted the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31st March,2020.29-06-2020
ALPA LABORATORIES LTD. - 532878 - Outcome Of Board Meeting- Financial Results
Alpa Laboratories Limited has submitted the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31st March,2020.ALPA LABORATORIES LTD. - 532878 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Alpa Laboratories Limited has submitted the Annual Secretarial Compliance Report under the Regulation 24(A) of SEBI(LODR),2015 of the year ended 31st March,2020.ALPA LABORATORIES LTD. - 532878 - Board Meeting Intimation for Notice Of Board Meeting To Consider The Standalone And Consolidated Audited Financial Results For The Quarter & Year Ended On 31St March, 2020.
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve Alpa Laboratories Limited has informed to exchange that the board Meeting will be held on 29th June, 2020 to consider the Standalone and Consolidated Audited Financial Results for the Quarter & Year ended on 31st March, 2020.ALPA LABORATORIES LTD. - 532878 - Disclosure Under Regulation 40 (10) Of SEBI LODR Regulation''s,2015
Alpa laboratories has submitted the disclosure under regulation 40 (10) of SEBI LODR REGULATIONS, 2015ALPA LABORATORIES LTD. - 532878 - Compliance Certificate Under Regulation 7 (3) For The Half Year Ended March 31,2020
Alpa Laboratories submitted the disclosure under regulation 7 (3) for the half year ended March 31,2020ALPA LABORATORIES LTD. - 532878 - Shareholding for the Period Ended March 31, 2020
Alpa Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click hereALPA LABORATORIES LTD. - 532878 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Alpa Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.ALPA LABORATORIES LTD. - 532878 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Megha NeemaDesignation :- Company Secretary and Compliance OfficerALPA LABORATORIES LTD. - 532878 - Clarification sought from Alpa Laboratories Ltd
The Exchange has sought clarification from Alpa Laboratories Ltd on April 13, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.ALPA LABORATORIES LTD. - 532878 - Closure of Trading Window
Alpa Laboratories Limited has submitted the disclosure for Closure of Trading Window.